Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group
Authors:
- Francesco MarchesiFMFrancesco Marchesi
- Corrado GirmeniaCGCorrado Girmenia
- Enrico Maria TrecarichiETEnrico Maria Trecarichi
- Alfonso PiciocchiAPAlfonso Piciocchi
- Alessandro BuscaAlessandro Busca
- Anna CandoniACAnna Candoni
- Chiara CattaneoCCChiara Cattaneo
- Maria Ilaria Del PrincipeMPMaria Ilaria Del Principe
- Luana FianchiLFLuana Fianchi
- Giuseppe GentileGGGiuseppe Gentile
- Nicola Stefano FracchiollaNFNicola Stefano Fracchiolla
Open Access
- 20 June 2026
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 77, 101412
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana Contro le Leucemie - Linfomi e Mieloma
This publication has 169 references indexed in Scilit:
- Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA‐EPIFLUEHA ReportAmerican Journal of Hematology, 2024
- Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical TrialAmerican Journal of Hematology, 2024
- Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemiaAmerican Journal of Hematology, 2023
- Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with VenetoclaxAmerican Journal of Hematology, 2023
- Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemiaAmerican Journal of Hematology, 2022
- Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemiaAmerican Journal of Hematology, 2022
- Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agentsAmerican Journal of Hematology, 2020
- Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemiaAmerican Journal of Hematology, 2017
- High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk‐oriented consolidation: A critical review of a 10‐year, single‐center experience in younger, non M3 AML patientsAmerican Journal of Hematology, 2016
- Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter studyAmerican Journal of Hematology, 2012